Approval · Notice of Compliance 22291 · 2019
EVENITY: Notice of Compliance 22291
Issued June 17, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 22291
- Date
- June 17, 2019
- Company
- Amgen Canada IncMississauga, Ontario, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| EVENITY | 02489597 | Marketed |
Medicinal ingredients
- ROMOSOZUMAB 90 MG per ML